Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-16269110 in Type 2 Diabetes Mellitus
NCT00672386Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of usistapide in type 2 diabetes mellitus (T2DM), sponsored by Johnson & Johnson. Started Dec 2007; status: completed.
02
Drugs
usistapide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00672386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672386.